English 
搜索
Hebei Lansheng Biotech Co., Ltd. ShangHai Yuelian Biotech Co., Ltd.

Lianhe Technology 2011 Sales Increased by 30%qrcode

Apr. 9, 2012

Favorites Print
Forward
Apr. 9, 2012

Lianhe Technology 2011 Sales Increased by 30%


The 2011 operation results recently announced by the technological service-oriented Chinese company – Lianhe Technology reveals its business income of RMB2.57 billion Yuan and profit of RMB346.04 million Yuan which are respectively 30.13% and 39.47% up year on year; the net profit attributable to its mother company reached RMB294.34 million Yuan, being 45.01% up year on year.

Lianhe Technology 2011 Sales Indicators by Income (in 10,000 CNY)
Primary Business
Business Income
YOY Growth (%)
Gross Profit (%)
YOY Growth (%)
Industrial Production
179,171.82
42.80
38.03
-1.72
-Pharmaceutical Intermediates
31,097.10
23.09
37.15
2.80
-Agrochemical
Intermediates
132,147.82
44.43
39.87
-2.42
- Miscellaneous
15,926.90
82.82
24.50
-4.24
Trading
77,632.68
8.01
1.85
-0.43
Total
256,804.50
30.13
27.09
0.99

The business scope of Lianhe Technology includes industrial production and trading activities; its industrial production income in the report period reached RMB1.79 billion Yuan, being 42.8% up year on year. Statistics by industrial categories shows 23% increase of pharmaceutical intermediates, 44% increase of agrochemical intermediates and 82% increase of miscellaneous businesses; statistics by territory of trade shows 120% increase in Asian market which is the highest growth region, followed by Europe and US market.

Lianhe Technology 2011 Sales Indicators by Region (in 10,000 CNY)
Regions
Business Income
YOY Growth (%)
Home Market
38,759.93
57.13
Europe
33,994.85
72.99
USA
94,382.44
24.70
Asia
12,034.61
120.21
Industrial Production Subtotal
179,171.82
42.80
Home Market
11,958.89
-68.40
Overseas Market
65,673.79
93.00
Trading Business Subtotal
77,632.68
8.01
Total
256,804.50
30.13


Strategic Deployment of Lianhe Technology

- Core Technology Synergism

As technological service oriented, Lianhe Technology utilizes its 8 core technologies – ammoxidation, fluorination, hydrogenation reduction, cyclization, nucleotide series reaction, Grignard reaction, Suzuki coupling reaction and ultra-low temperature reaction to provide customers with individualized and customized manufacturing service backed up by its quality, technology, continued innovation and prompt response.

- Key Account Strategy

Through its technological synergy operation mode, Lianhe Technology is well recognized by international pharmaceutical, agrochemical and chemical manufacturers, thus forming a core customer portfolio comprising world prime industry players, which paves the way for long-term cooperation with these industry leaders on a win-win basis. So far Lianhe Technology has established partnership with the world’s 12 top agrochemical and pharmaceutical manufacturers, among them FMC and Syngenta have achieved 10% growth in agrochemical industry which would provide Lianhe Technology with promising future prospects.

- Industrial Chain Extension

To extend and develop the industrial chain, Lianhe Technology has enhanced its chain industry deployment to provide existing customers with the very rare phosgene and fluorination services. Via an increase of its share capital, Lianhe Technology has become a controlling shareholder of Shandong Pingyuan Yongheng Chemicals Ltd, a phosgene producer; and has also acquired Liaoning Tianyu Chemicals, a fluorination producer. These measures as being taken will effectively help Lianhe Technology to move toward deployment of more diversified product series while bringing benefit to raw material cost reduction in the years ahead.

Source: AgroNews

0/1200

More from AgroNewsChange

Hot Topic More

I wanna post a press Comment

Subscribe 

Subscribe Email: *
Name:
Mobile Number:  

Comment  

0/1200

 

NEWSLETTER

Subscribe China Special Biweekly to send news related to your mailbox